GuidelineInternal medicine journal2026
Achieving effective medicines governance: guiding principles for the roles and responsibilities of Medicines and Therapeutics Committees in Australian hospitals.
Guideline in Internal medicine journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Achieving effective medicines governance: guiding principles for the roles and responsibilities of Medicines and Therapeutics Committees in Australian hospitals.Internal medicine journal · 2026Guideline
- A Framework for Ethical and Clinical Governance Evaluation of Innovative Medicines in Children: A Mixed Methods Study.Journal of paediatrics and child health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Robust medicines governance is an essential component of good clinical governance for health service organisations. Standardisation of hospital medicines governance supports consistency in clinical care and equity in medicines access for patients both within those hospitals and at transitions of care. Medicines and Therapeutics Committees (MTCs) provide the strategic lead for medicines governance in Australian hospitals and have done so for many decades. Changes to the healthcare environment in which MTCs operate, however, have necessitated adaptation and evolution of these committees. Contemporary guidance is therefore required to support MTCs to provide consistent, high-quality medicines governance in Australia's modern healthcare environment. Achieving effective medicines governance: Guiding principles for the roles and responsibilities of Medicines and Therapeutics Committees in Australian hospitals was released in July 2025 with recommendations for the purpose, functions, structure, processes, documentation, communication and resourcing for Australian MTCs. The guidance is accompanied by a checklist to measure the performance of MTCs and other supporting resources. Australian hospital MTCs are encouraged to measure their practice against these guiding principles, using the associated tools, to achieve the best possible medicines governance within their available resourcing. Practice across jurisdictions is variable, and working to align individual MTC practices with the guiding principles will promote standardisation in approach to hospital medicines governance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.